Pulmonx Corporation LUNG Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's deferred revenue?
- Pulmonx Corporation (LUNG) reported deferred revenue of $32K in Q1 2026.
- How has Pulmonx Corporation's deferred revenue changed year-over-year?
- Pulmonx Corporation's deferred revenue decreased by 75.0% year-over-year, from $128K to $32K.
- What is the long-term trend for Pulmonx Corporation's deferred revenue?
- Over 5 years (2020 to 2025), Pulmonx Corporation's deferred revenue has grown at a -24.0% compound annual growth rate (CAGR), from $71K to $18K.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.